First Do No Harm? Modeling Risks and Benefits of Challenge Trials for Hepatitis C Vaccine Development. Bilinski A, Slimovitch R, Mendlowitz A, Feld JJ, et al. Clin Infect Dis 2023;77.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Bilinski A, Slimovitch R, Mendlowitz A, Feld JJ, et al. First Do No Harm? Modeling Risks and Benefits of Challenge Trials for Hepatitis C Vaccine Development. Clin Infect Dis 2023;77.
PMID: 37579207